Highest return-on-assets companies
Companies ranked by trailing return on assets (ROA) — how efficiently a business turns its asset base into profit. Delayed fundamentals from market data, shown with their as-of date.
Ranked by ROA: companies 2,951–2,975 of 3,067.
| # | Company | Sector | ROA | Net margin | Market cap |
|---|---|---|---|---|---|
| 2951 | American Battery Technology Compan (ABAT) | Materials | -55.2% | -337.5% | $190M |
| 2952 | Brand Engagement Network Inc (BNAI) | Information Technology | -56.4% | -3135.2% | $33M |
| 2953 | Insmed (INSM) | Health Care | -56.4% | -210.5% | $25.1B |
| 2954 | Lineage Cell Therapeutics Inc (LCTX) | Health Care | -56.4% | -436.5% | $258M |
| 2955 | AN2 Therapeutics Inc (ANTX) | Health Care | -56.8% | n/a | $151M |
| 2956 | Energous Corporation (WATT) | Industrials | -57.3% | n/a | $42M |
| 2957 | C3.ai Inc Class A (AI) | Information Technology | -57.6% | -187.9% | $1.9B |
| 2958 | SKYX Platforms Corp. (SKYX) | Industrials | -57.9% | -36.3% | $99M |
| 2959 | Starfighters Space Inc (FJET) | Industrials | -58.3% | n/a | $201M |
| 2960 | Nektar Therapeutics (NKTR) | Health Care | -58.5% | -297.1% | $1.3B |
| 2961 | Sana Biotechnology Inc (SANA) | Health Care | -58.6% | n/a | $710M |
| 2962 | Prime Medicine Inc (PRME) | Health Care | -58.7% | -4342.4% | $843M |
| 2963 | Alumis Inc (ALMS) | Health Care | -59.1% | -1011.7% | $780M |
| 2964 | Veritone Inc (VERI) | Information Technology | -59.4% | -121.2% | $49M |
| 2965 | Gloo Holdings, Inc. (GLOO) | Information Technology | -59.6% | -166.0% | $249M |
| 2966 | Zura Bio Limited Class A (ZURA) | Health Care | -60.2% | n/a | $394M |
| 2967 | Relmada Therapeutics Inc (RLMD) | Health Care | -61.0% | n/a | $416M |
| 2968 | Tenaya Therapeutics, Inc. (TNYA) | Health Care | -61.7% | n/a | $82M |
| 2969 | Aura Biosciences Inc (AURA) | Health Care | -62.7% | n/a | $680M |
| 2970 | WW International, Inc. (WW) | Consumer Discretionary | -62.8% | -44.0% | $113M |
| 2971 | Plug Power Inc (PLUG) | Industrials | -62.9% | -229.8% | $2.0B |
| 2972 | Cue Biopharma, Inc. (CUE) | Health Care | -63.0% | -96.9% | $136M |
| 2973 | EyePoint Inc (EYPT) | Health Care | -63.7% | -739.4% | $31M |
| 2974 | Artiva Biotherapeutics Inc (ARTV) | Health Care | -64.0% | n/a | $203M |
| 2975 | Crescent Biopharma Inc (CBIO) | Health Care | -64.1% | -1419.6% | $503M |
Find more highest return-on-assets companies like these →
Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Every figure is shown with its as-of date on the company page; a company with no data for this metric is excluded from the ranking, never estimated.
Last updated 2026-11-06 — rankings shift as the underlying data refreshes.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.